A 4.7 fold down regulation of VIM expression and absence of vimentin immunoreactivity in the in situ tumor compared to normal mammary cells suggests both the tumor and the derived cell line have not undergone an epithelial-to-mesenchymal transition associated with increased invasive/migratory properties of epithelial cells [43,44]. This evidence concerns the gene VIM and neoplasm.